RICHMOND, Va. / Sep 09, 2024 / Business Wire / Owens & Minor, Inc. (NYSE: OMI), announced today that Ed Pesicka, the Company’s President and Chief Executive Officer and Jon Leon, Corporate Treasurer and interim Chief Financial Officer, will participate in a fireside chat at 1:25 p.m. Eastern Daylight Time on Tuesday, September 10, 2024 at Baird’s Global Healthcare Conference in New York City. Owens & Minor is also hosting one-on-one meetings with investors at the conference.
About Owens & Minor
Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home. For over 100 years, Owens & Minor and its affiliated brands, Apria®, Byram® and HALYARD*, have helped to make each day better for the patients, providers, and communities we serve. Powered by more than 20,000 teammates worldwide, Owens & Minor delivers comfort and confidence behind the scenes so healthcare stays at the forefront. Owens & Minor exists because every day, everywhere, Life Takes Care™. For more information about Owens & Minor and our affiliated brands, visit owens-minor.com or follow us on LinkedIn and Instagram.
| Last Trade: | US$12.00 |
| Daily Change: | -1.25 -9.43 |
| Daily Volume: | 1,813,213 |
| Market Cap: | US$925.200M |
November 04, 2024 September 10, 2024 August 02, 2024 July 23, 2024 July 23, 2024 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
